国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Sclerotinia sclerotiorum Amino-acid acetyltransferase, mitochondrial (arg2), partial CSB-YP411422STG
CSB-EP411422STG
CSB-BP411422STG
CSB-MP411422STG
CSB-EP411422STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Mannitol-1-phosphate 5-dehydrogenase (SS1G_14022) CSB-YP411423STG
CSB-EP411423STG
CSB-BP411423STG
CSB-MP411423STG
CSB-EP411423STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Nascent polypeptide-associated complex subunit beta (egd1) CSB-YP411424STG
CSB-EP411424STG
CSB-BP411424STG
CSB-MP411424STG
CSB-EP411424STG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sclerotinia sclerotiorum Solute carrier family 25 member 38 homolog (SS1G_14414), partial CSB-YP411425STG1
CSB-EP411425STG1
CSB-BP411425STG1
CSB-MP411425STG1
CSB-EP411425STG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b ATPase ravA (ravA), partial CSB-YP411426YAN
CSB-EP411426YAN
CSB-BP411426YAN
CSB-MP411426YAN
CSB-EP411426YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Der GTPase-activating protein YihI (yihI) CSB-YP411427YAN
CSB-EP411427YAN
CSB-BP411427YAN
CSB-MP411427YAN
CSB-EP411427YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Ribonuclease PH (rph) CSB-YP411428YAN
CSB-EP411428YAN
CSB-BP411428YAN
CSB-MP411428YAN
CSB-EP411428YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 50S ribosomal protein L28 (rpmB) CSB-YP411429YAN
CSB-EP411429YAN
CSB-BP411429YAN
CSB-MP411429YAN
CSB-EP411429YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Met repressor (metJ) CSB-YP411430YAN
CSB-EP411430YAN
CSB-BP411430YAN
CSB-MP411430YAN
CSB-EP411430YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b tRNA (uracil (54)-C (5))-methyltransferase CSB-YP411431YAN
CSB-EP411431YAN
CSB-BP411431YAN
CSB-MP411431YAN
CSB-EP411431YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b ATP-dependent RNA helicase rhlB (rhlB) CSB-YP411432YAN
CSB-EP411432YAN
CSB-BP411432YAN
CSB-MP411432YAN
CSB-EP411432YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Protein CyaY (cyaY) CSB-YP411433YAN
CSB-EP411433YAN
CSB-BP411433YAN
CSB-MP411433YAN
CSB-EP411433YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP411434YAN1
CSB-EP411434YAN1
CSB-BP411434YAN1
CSB-MP411434YAN1
CSB-EP411434YAN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Homoserine O-succinyltransferase (metA) CSB-YP411435YAN
CSB-EP411435YAN
CSB-BP411435YAN
CSB-MP411435YAN
CSB-EP411435YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b DNA-binding protein fis (fis) CSB-YP411436YAN
CSB-EP411436YAN
CSB-BP411436YAN
CSB-MP411436YAN
CSB-EP411436YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b 3-dehydroquinate dehydratase (aroQ) CSB-YP411437YAN
CSB-EP411437YAN
CSB-BP411437YAN
CSB-MP411437YAN
CSB-EP411437YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b p-hydroxybenzoic acid efflux pump subunit AaeB (aaeB), partial CSB-YP411438YAN
CSB-EP411438YAN
CSB-BP411438YAN
CSB-MP411438YAN
CSB-EP411438YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b UPF0042 nucleotide-binding protein YpsIP31758_0438 (YpsIP31758_0438) CSB-YP411439YAN
CSB-EP411439YAN
CSB-BP411439YAN
CSB-MP411439YAN
CSB-EP411439YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b DnaA initiator-associating protein diaA (diaA) CSB-YP411440YAN
CSB-EP411440YAN
CSB-BP411440YAN
CSB-MP411440YAN
CSB-EP411440YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype O:1b Ribosomal RNA large subunit methyltransferase G (rlmG) CSB-YP411441YAN
CSB-EP411441YAN
CSB-BP411441YAN
CSB-MP411441YAN
CSB-EP411441YAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>